Introduction
The mechanism of development of renal osteodystrophy has been the subject of controversy for many years. Owing to this condition's resemblance to nutritional rickets, vitamin D was initially considered to be the major factor involved. Albright and Reifenstein (1948) discounted this theory claiming that parathyroid hypertrophy was the dominant feature. In 1968, Stanbury suggested that a defect in the metabolism of vitamin D was present in chronic renal failure. This was later shown to be a deficiency in 1,a-hydroxylase activity in the kidney resulting in low serum levels of 1,25 dihydroxyvitamin D3 (1,25(OH)2D3) in chronic renal failure (Mawer et al., 1973) . There is also a high circulating level of immunoreactive parathyroid hormone (PTH) in renal failure, the origin of which is multifactorial (Papapoulos et al., 1977) .
The investigation of the pathogenesis of renal bone disease is complicated by several of the features of uraemia including acidosis, inadequate nutrition and the effects of dialysis. A (Table 1) . A trans-iliac bone biopsy revealed 2 to 3 seams of osteoid covering most of tht trabecular bone surface ( Fig. 3(a) ) but cellular details were obscured owing to a technical difficulty in staining.
In August 1976, treatment was commenced with 2 ,ug/day of lcxOHD3. Calcium absorption 4 months later showed a marked improvement (Table 1) . The serum Ca rose to the lower limit of normal within 4 months but phosphate concentrations did not return to the normal range for a further 4 months (Fig. 4) . Serum concentrations of PTH also returned to normal values at 8 months. The appearances of a further bone biopsy after 4 months of treatment were normal ( Fig. 3(b) ) and radiological bone resorption also disappeared (Fig. 2(b) ). (Soriano et al., 1966; Stoop, Schraagen and Tiddens, 1967; Dent, Friedman and Watson, 1968; Fanconi and Prader, 1969; Birtwell et al., 1970; Salenius, Lindholm and Tierala, 1973) . Arnaud et al. (1970) considered the abnormality to be due to defective synthesis of 25 OHD3 but Balsan and Garabedian (1972) and Cohamin, de Luca and Yendt (1973) demonstrated resistance also to 25 OHD3. Fraser et al. (1973) showed that minute doses of 1,25(OH)2D3 were able to improve the bone lesions and postulated that a genetic defect in 25 OHD3-lO Ohydroxylase activity was present.
Elevated PTH levels in pseudo-vitamin D deficiency rickets fell in response to calcium infusion (Falls et al., 1968) or treatment with vitamin D (Arnaud et al., 1970) . Fanconi and Prader (1969) were able to find a response to exogenous PTH only when the rickets were radiologically healed. However, Rosen and Finberg (1973) found a prompt response in urinary cyclic AMP to PTH in 3 patients with pseudo-vitamin D deficiency.
Although there are some features in common between renal osteodystrophy and pseudo-vitamin D deficiency, the low serum phosphate in the latter condition makes direct comparison impossible.
Sub-periosteal bone resorption and elevated PTH concentrations confirmed the presence of hyperparathyroidism in the present patient. The radiological appearances of primary hyperparathyroidism can simulate rickets (Fretheim and Gardborg, 1965) . Lack of response to exogenous PTH indicates 'end-organ resistance' described by Albright et al. show neither radiological defects in bone structure nor a raised serum alkaline phosphatase suggesting that the bones are also resistant to the action of PTH. Singleton and Teng (1962) described a patient with biochemical features of pseudo-hypoparathyroidism but without the associated somatotype abnormalities. Radiographic evidence of bone resorption was present. The following year Costello and Dent (1963) , describing a similar case in which radiological healing was achieved with large doses of vitamin D, named the condition hypohyperparathyroidism.
In a further 5 cases (Bell, Gerard and Bartter, 1963; Allen, Millard and Nassim, 1968; Cohen and Vince, 1969; Frame et al., 1972) , histological examination of bone was performed before treatment. In 3 the appearances were compatible with osteitis fibrosa cystica but in the other 2 the predominant feature was an increase in osteoid. Only case 1 of Frame et al. (1972) failed to show radiological improvement in bone resorption on treatment with high doses of vitamin D, but in only 2 patients was the improvement confirmed by histology (Allen et al., 1968; Bell et al., 1963) . The osteoid present in the present case was excessive both in volume and the extent of trabecular bone surface covered, while the radiological features were those of hyperparathyroidism. The lack of renal response to PTH in the presence of response by bone does not explain the hypocalcaemia in hypohyperparathyroidism. Ca absorption improved on therapy in 3 of the previously described patients with hypohyperparathyroidism similar to the response, in the present patient, to locOHD3. PTH is recognized not to act directly on the intestine but it increases Ca absorption by stimulating the production of 1,25(OH)2D3 (Garabedian et al., 1974; Ribovich and de Luca, 1976) .
The low serum 1,25(OH)2D3 level in this patient could be due to either a failure of response to PTH (Garabedian et al., 1974; Gerblich, Genuth and Haddad, 1977) . Bone resorption in the present patient was less than might be expected with the concentrations of PTH similar to the resistance of bone to PTH in uraemia, attributed by Massry et al. (1976) The pathogenesis of hypohyperparathyroidism is best explained by a defect in the renal receptor site for PTH. A common receptor site for both the effect on phosphate excretion and 1,oc-hydroxylase activity would result in hyperphosphataemia and low serum levels of 1,25(0H)2D3 leading to hypocalcaemia. The resultant elevated PTH levels would have no effect on the kidney and, owing to the low 1,25(OH)2D3 concentrations, there would also be a relative resistance of the skeleton to PTH.
Damage to the receptor site for PTH from ischaemia, reflux nephropathy or other tubular lesions would also lead to the above features. Thus a single pathological lesion could explain the previous controversy over the development of the major features of renal osteodystrophy.
